Middlemen Play Gatekeeper in Battle to Curb Soaring Drug Costs
Nektar Therapeutics Is Said to Weigh Options Including Sale
Gilead Slips as Sales of Blockbuster Hepatitis Treatments Fade
Nasdaq biotech index rebounds after Trump blasts drug makers.
With Juno, Celgene gains cutting edge CAR-T cancer technology.
Generic-Drug Makers Fall as Justice Department Threatens to Sue
America’s Home Nurse Shortage Is Stranding Kids in Hospitals
Biotech CEO Turned Failed Sanofi Drug Into Multibillion Deal
It’s hard to imagine Amazon being anything more than a niche grocery player without pharmacies.
Medicare Rigid Billing System Leaves Gilead Cancer Drug in Limbo
Only a handful of patients got the costly Gilead’s treatment, while others linger on waiting lists.
Pharma Lobby Group Sues to Block California's Drug Pricing Law
Sam Isaly, the managing partner of OrbiMed Advisors, sexually harassed a series of women, according to Stat report.
Trump White House Logs Document Drug Industry Visitors, Meetings
‘Justice League’ Superheroes Save World, Miss Forecasts
For Moderna Therapeutics, the road to a cancer breakthrough begins on the back of a FedEx truck.
Sensor in depression pill transmits data to a smartphone app.
Anthem CEO Joseph Swedish Is Said to Plan Departure, WSJ Reports
Mylan NV’s second-ranked executive took an active role in a vast and “sinister” price-fixing conspiracy.
Drugmakers' Rare Disease R&D Incentives Are Cut in GOP Tax Bill
Mylan Woes Get Worse With Top Executive Engulfed in Vast Probe